The significant reduction in tumor sizes, Ki67 staining, and lung adenocarcinoma development in mouse models demonstrates dauricine’s capability to inhibit tumor proliferation and progression with in vivo systems [63,67]. The gene discussed is MKI67; the disease is lung adenocarcinoma.